# PRV-015 in Gluten-free Diet Non-responsive Celiac Disease

> **NCT04424927** · PHASE2 · COMPLETED · sponsor: **Provention Bio, a Sanofi Company** · enrollment: 388 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **BIOLOGICAL:** PRV-015
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04424927
- **Lead sponsor:** Provention Bio, a Sanofi Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-24
- **Primary completion:** 2024-07-30
- **Final completion:** 2024-07-30
- **Target enrollment:** 388 (ACTUAL)
- **Last updated:** 2025-10-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04424927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04424927, "PRV-015 in Gluten-free Diet Non-responsive Celiac Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04424927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*